206 related articles for article (PubMed ID: 32023822)
1. Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H
Aasarød KM; Waldum HL; Stunes AK; Sandvik AK; Flatberg A; Mjønes P; Syversen U; Bakke I; Fossmark R
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023822
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach.
Bockerstett KA; Lewis SA; Wolf KJ; Noto CN; Jackson NM; Ford EL; Ahn TH; DiPaolo RJ
Gut; 2020 Jun; 69(6):1027-1038. PubMed ID: 31481545
[TBL] [Abstract][Full Text] [Related]
3. Mucosal expression of aquaporin-4 in the stomach of histamine type 2 receptor knockout mice and Helicobacter pylori-infected mice.
Fukuhara S; Matsuzaki J; Tsugawa H; Masaoka T; Miyoshi S; Mori H; Fukushima Y; Yasui M; Kanai T; Suzuki H
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():53-9. PubMed ID: 25521734
[TBL] [Abstract][Full Text] [Related]
4. Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice.
Aasarød KM; Ramezanzadehkoldeh M; Shabestari M; Mosti MP; Stunes AK; Reseland JE; Beisvag V; Eriksen EF; Sandvik AK; Erben RG; Schüler C; Boyce M; Skallerud BH; Syversen U; Fossmark R
J Endocrinol; 2016 Aug; 230(2):251-62. PubMed ID: 27325243
[TBL] [Abstract][Full Text] [Related]
5. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.
Jeong H; Lee B; Kim KH; Cho SY; Cho Y; Park J; Lee Y; Oh Y; Hwang BR; Jang AR; Park JH; Park JH; Jeong SH; Lee D; Lee YC; Lim KM; Goldenring JR; Nam KT
Gastroenterology; 2021 Sep; 161(3):953-967.e15. PubMed ID: 34116028
[TBL] [Abstract][Full Text] [Related]
6. PAI-1 deficiency increases the trophic effects of hypergastrinemia in the gastric corpus mucosa.
Fossmark R; Rao S; Mjønes P; Munkvold B; Flatberg A; Varro A; Thommesen L; Nørsett KG
Peptides; 2016 May; 79():83-94. PubMed ID: 27038741
[TBL] [Abstract][Full Text] [Related]
7. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
8. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and potential therapeutic mechanism of Weiwei decoction on Spasmolytic polypeptide-expressing metaplasia in Helicobacter pylori-infected and Atp4a-knockout mice.
Hong X; Li H; Lin Y; Luo L; Xu W; Kang J; Li J; Huang B; Xu Y; Pan H; Guo S
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117062. PubMed ID: 37598768
[TBL] [Abstract][Full Text] [Related]
10. Tropism for Spasmolytic Polypeptide-Expressing Metaplasia Allows Helicobacter pylori to Expand Its Intragastric Niche.
Sáenz JB; Vargas N; Mills JC
Gastroenterology; 2019 Jan; 156(1):160-174.e7. PubMed ID: 30287170
[TBL] [Abstract][Full Text] [Related]
11. Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels.
Yamagata Y; Aikou S; Fukushima T; Kataoka H; Seto Y; Esumi H; Kaminishi M; Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1254-61. PubMed ID: 23064758
[TBL] [Abstract][Full Text] [Related]
12. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
[TBL] [Abstract][Full Text] [Related]
13. Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.
Boyce M; Dowen S; Turnbull G; van den Berg F; Zhao CM; Chen D; Black J
Br J Clin Pharmacol; 2015 May; 79(5):744-55. PubMed ID: 25335860
[TBL] [Abstract][Full Text] [Related]
14. Evidence for heightened genetic instability in precancerous spasmolytic polypeptide expressing gastric glands.
Chen J; Zhu C; Wang C; Hu C; Czajkowsky DM; Guo Y; Liu B; Shao Z
J Med Genet; 2020 Jun; 57(6):385-388. PubMed ID: 30877236
[TBL] [Abstract][Full Text] [Related]
15. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I
PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
Nam KT; Varro A; Coffey RJ; Goldenring JR
Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
[TBL] [Abstract][Full Text] [Related]
17. Deoxycholic acid-stimulated macrophage-derived exosomes promote spasmolytic polypeptide-expressing metaplasia in the stomach.
Xu X; Cheng J; Luo S; Gong X; Huang D; Xu J; Qian Y; Wan X; Zhou H
Biochem Biophys Res Commun; 2020 Apr; 524(3):649-655. PubMed ID: 32033746
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
[TBL] [Abstract][Full Text] [Related]
19. Group 2 Innate Lymphoid Cells Coordinate Damage Response in the Stomach.
Meyer AR; Engevik AC; Madorsky T; Belmont E; Stier MT; Norlander AE; Pilkinton MA; McDonnell WJ; Weis JA; Jang B; Mallal SA; Peebles RS; Goldenring JR
Gastroenterology; 2020 Dec; 159(6):2077-2091.e8. PubMed ID: 32891625
[TBL] [Abstract][Full Text] [Related]
20. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
